Pfm Health Sciences, LP Voyager Therapeutics, Inc. Transaction History

Pfm Health Sciences, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $15.8 Million - $20.8 Million	-1,231,954 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$16.31 - $28.29 $14.4 Million - $25 Million	-885,434 Reduced 41.82%	1,231,954 $21.2 Million
Q2 2019 Aug 14, 2019	BUY	$19.18 - $27.88 $3.19 Million - $4.64 Million	166,327 Added 8.52%	2,117,388 $57.6 Million
Q1 2019 May 15, 2019	BUY	$8.0 - $19.66 $15.6 Million - $38.4 Million	1,951,061 New	1,951,061 $37.3 Million
Q4 2017 Feb 14, 2018	SELL	$12.26 - $25.88 $4.88 Million - $10.3 Million	-397,923 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$8.37 - $20.59 $3.33 Million - $8.19 Million	397,923	397,923 $8.19 Million

134

34.1M

60.4K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $123M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

Stay updated on Pfm Health Sciences, LP with notifications on news.